NO20084542L - Farmasoytisk kombinasjon inneholdende 3-(3-dimetylamino-1-etyl-2-metyl-propyl)-fenol og paracetamol - Google Patents
Farmasoytisk kombinasjon inneholdende 3-(3-dimetylamino-1-etyl-2-metyl-propyl)-fenol og paracetamolInfo
- Publication number
- NO20084542L NO20084542L NO20084542A NO20084542A NO20084542L NO 20084542 L NO20084542 L NO 20084542L NO 20084542 A NO20084542 A NO 20084542A NO 20084542 A NO20084542 A NO 20084542A NO 20084542 L NO20084542 L NO 20084542L
- Authority
- NO
- Norway
- Prior art keywords
- paracetamol
- dimethylamino
- phenol
- propyl
- ethyl
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
- A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Abstract
Det er beskrevet en kombinasjon omfattende som komponenter (a) forbindelsen 3-(3dimetylamino-1-etyl-2-metyl-propyl)-fenol og (b) paracetamol eller et derivat derav, et farmasøytisk preparat og en doseringsform omfattende nevnte kombinasjon så vel som en fremgangsmåte for behandling av smerte, for eksempel kronisk eller akutt smerte, kjennetegnet ved at komponenter (a) og (b) administreres samtidig eller trinnvis til et pattedyr, hvori komponent (a) kan administreres før eller komponent (b) og hvori komponentene (a) eller (b) administreres til pattedyret enten via samme eller forskjellig administrasjonsvei.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP06008851 | 2006-04-28 | ||
PCT/EP2007/003632 WO2007128413A1 (en) | 2006-04-28 | 2007-04-25 | Pharmaceutical combination comprising 3- ( 3-dimethylamino-1-ethyl-2-methyl-propyl) -phenol and paracetamol |
Publications (2)
Publication Number | Publication Date |
---|---|
NO20084542L true NO20084542L (no) | 2008-10-28 |
NO341602B1 NO341602B1 (no) | 2017-12-11 |
Family
ID=37025148
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20084542A NO341602B1 (no) | 2006-04-28 | 2008-10-28 | Farmasøytisk kombinasjon omfattende 3-(3-dimetylamino-1-etyl-2-metyl-propyl)-fenol og paracetamol |
NO20171831A NO343505B1 (no) | 2006-04-28 | 2017-11-17 | Farmasøytisk kombinasjon omfattende 3-(3-dimetylamino-1-etyl-2-metylpropyl)-fenyl og paracetamol |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20171831A NO343505B1 (no) | 2006-04-28 | 2017-11-17 | Farmasøytisk kombinasjon omfattende 3-(3-dimetylamino-1-etyl-2-metylpropyl)-fenyl og paracetamol |
Country Status (25)
Country | Link |
---|---|
EP (1) | EP2012764B1 (no) |
JP (2) | JP5496653B2 (no) |
KR (1) | KR101396166B1 (no) |
CN (1) | CN101431990B (no) |
AT (1) | ATE494889T1 (no) |
AU (1) | AU2007247481B2 (no) |
BR (1) | BRPI0710682B8 (no) |
CA (1) | CA2650423C (no) |
CY (1) | CY1111369T1 (no) |
DE (1) | DE602007011913D1 (no) |
DK (1) | DK2012764T3 (no) |
EC (2) | ECSP088793A (no) |
ES (1) | ES2356093T3 (no) |
HK (1) | HK1127289A1 (no) |
HR (1) | HRP20110076T1 (no) |
IL (1) | IL194883A (no) |
MX (1) | MX2008013779A (no) |
NO (2) | NO341602B1 (no) |
NZ (1) | NZ571442A (no) |
PL (1) | PL2012764T3 (no) |
PT (1) | PT2012764E (no) |
RU (1) | RU2442576C2 (no) |
SI (1) | SI2012764T1 (no) |
WO (1) | WO2007128413A1 (no) |
ZA (1) | ZA200810124B (no) |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE102007012165A1 (de) | 2007-03-12 | 2008-09-18 | Grünenthal GmbH | Verwendung von 1-Phenyl-3-dimethylamino-propanverbindungen zur Therapie des Neuropathieschmerzes |
KR101784777B1 (ko) * | 2007-11-23 | 2017-11-06 | 그뤼넨탈 게엠베하 | 타펜타돌 조성물 |
PL2582366T3 (pl) | 2010-06-15 | 2016-04-29 | Gruenenthal Gmbh | Kombinacja farmaceutyczna do leczenia bólu |
MX344473B (es) | 2011-03-04 | 2016-12-16 | Gruenenthal Gmbh | Composicion farmaceutica acuosa semisolida que contiene tapentadol. |
LT2680832T (lt) | 2011-03-04 | 2019-10-25 | Gruenenthal Gmbh | Tapentadolio vandeninė farmacinė kompozicija, skirta vartoti geriant |
RS54711B1 (en) * | 2011-03-04 | 2016-08-31 | Grünenthal GmbH | PARENTERAL TAPENTADOL ADMINISTRATION |
US20130310385A1 (en) | 2012-05-18 | 2013-11-21 | Gruenenthal Gmbh | Pharmaceutical Composition Comprising (1r,4r)-6'-fluoro-N,N-dimethyl-4-phenyl-4',9'-dihydro-3'H-spiro[cyclohexane-1,1'-pyrano[3,4,b]indol]-4-amine and Antidepressants |
US9855286B2 (en) | 2012-05-18 | 2018-01-02 | Gruenenthal Gmbh | Pharmaceutical composition comprising (1r,4r)-6′-fluoro-N,N-di methyl-4-phenyl-4′,9′-dihydro-3′H-spiro[cyclohexane-1,1′-pyrano-[3,4,b]indol]-4-amine and a salicylic acid component |
US20130310435A1 (en) | 2012-05-18 | 2013-11-21 | Gruenenthal Gmbh | Pharmaceutical Composition Comprising (1r,4r)-6'-fluoro-N, N-dimethyl-4-phenyl-4,9' -dihydro-3'H-spiro[cyclohexane-1,1' -pyrano[3,4,b]indol]-4-amine and Paracetamol or Propacetamol |
US9320729B2 (en) | 2012-05-18 | 2016-04-26 | Gruenenthal Gmbh | Pharmaceutical composition comprising (1r,4r)-6′-flouro-N,N-dimethyl-4-phenyl-4′,9′-dihydro-3′H-spiro[cyclohexane-1,1′-pyrano-[3,4,b]indol]-4-amine and a propionic acid derivative |
EP2808319A1 (en) | 2013-05-31 | 2014-12-03 | Arevipharma GmbH | 3-[3-(Dimethylamino)-1-ethyl-2-methylpropyl]phenol resin complex |
PT3479823T (pt) | 2015-03-27 | 2020-09-29 | Gruenenthal Gmbh | Formulação estável para administração parentérica de tapentadol |
KR20190057349A (ko) | 2016-09-23 | 2019-05-28 | 그뤼넨탈 게엠베하 | 타펜타돌의 비경구 투여용 안정한 제제 |
WO2018153947A1 (en) | 2017-02-23 | 2018-08-30 | Grünenthal GmbH | Tapentadol as local anesthetic |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE4426245A1 (de) * | 1994-07-23 | 1996-02-22 | Gruenenthal Gmbh | 1-Phenyl-3-dimethylamino-propanverbindungen mit pharmakologischer Wirkung |
PE20030527A1 (es) * | 2001-10-24 | 2003-07-26 | Gruenenthal Chemie | Formulacion farmaceutica con liberacion retardada que contiene 3-(3-dimetilamino-1-etil-2-metil-propil) fenol o una sal farmaceuticamente aceptable del mismo y tabletas para administracion oral que la contienen |
PT1562567T (pt) | 2002-11-22 | 2017-08-24 | Gruenenthal Gmbh | Combinação de analgésicos selecionados e inibidores da cox-ii |
-
2007
- 2007-04-25 MX MX2008013779A patent/MX2008013779A/es active IP Right Grant
- 2007-04-25 CN CN2007800148115A patent/CN101431990B/zh active Active
- 2007-04-25 SI SI200730498T patent/SI2012764T1/sl unknown
- 2007-04-25 PT PT07724562T patent/PT2012764E/pt unknown
- 2007-04-25 PL PL07724562T patent/PL2012764T3/pl unknown
- 2007-04-25 KR KR1020087028929A patent/KR101396166B1/ko active IP Right Grant
- 2007-04-25 NZ NZ571442A patent/NZ571442A/en unknown
- 2007-04-25 DK DK07724562.9T patent/DK2012764T3/da active
- 2007-04-25 RU RU2008146816/15A patent/RU2442576C2/ru active
- 2007-04-25 AU AU2007247481A patent/AU2007247481B2/en active Active
- 2007-04-25 WO PCT/EP2007/003632 patent/WO2007128413A1/en active Application Filing
- 2007-04-25 JP JP2009506978A patent/JP5496653B2/ja active Active
- 2007-04-25 AT AT07724562T patent/ATE494889T1/de active
- 2007-04-25 EP EP07724562A patent/EP2012764B1/en active Active
- 2007-04-25 BR BRPI0710682A patent/BRPI0710682B8/pt active IP Right Grant
- 2007-04-25 ES ES07724562T patent/ES2356093T3/es active Active
- 2007-04-25 DE DE602007011913T patent/DE602007011913D1/de active Active
- 2007-04-25 CA CA2650423A patent/CA2650423C/en active Active
-
2008
- 2008-10-06 EC EC2008008793A patent/ECSP088793A/es unknown
- 2008-10-23 IL IL194883A patent/IL194883A/en active IP Right Grant
- 2008-10-28 NO NO20084542A patent/NO341602B1/no unknown
- 2008-11-27 ZA ZA200810124A patent/ZA200810124B/xx unknown
-
2009
- 2009-06-25 HK HK09105733.2A patent/HK1127289A1/xx unknown
-
2011
- 2011-02-01 HR HR20110076T patent/HRP20110076T1/hr unknown
- 2011-04-05 CY CY20111100353T patent/CY1111369T1/el unknown
-
2013
- 2013-07-11 JP JP2013145481A patent/JP2013213045A/ja not_active Withdrawn
-
2017
- 2017-01-05 EC ECIEPI2017643A patent/ECSP17000643A/es unknown
- 2017-11-17 NO NO20171831A patent/NO343505B1/no unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ECSP17000643A (es) | Combinación farmacéutica que comprende 3-(3-dimetilamino-1etil-2-metil-propil)-fenol y Paracetamol. | |
ECSP17013617A (es) | combinación farmacéutica que comprende 3-(3-dimetilamino-1-etil-2-metil-propil)-fenol y nsaid | |
WO2010025931A3 (en) | Pharmaceutical combination of 3- (3-dimethylamino-1-ethyl-2 -methyl-propyl) - phenol and an antiepileptic | |
AU2016219643A1 (en) | Pharmaceutical combination for the treatment of pain | |
CY1118661T1 (el) | Φαρμακευτικη συνθεση, φαρμακευτικη δοσολογικη μορφη, διαδικασια για την παρασκευη τους, μεθοδοι για αντιμετωπιση και χρησεις αυτων | |
CY1119140T1 (el) | Συνθεσεις αντικωδικευσης και μεθοδοι κατασκευης και χρησης τους | |
EA201300121A1 (ru) | Ингибитор дпп-4 в комбинации с дополнительным противодиабетическим агентом, таблетки, включающие указанные композиции, их применение и способ их получения | |
NO20074999L (no) | Metode og preparat for behandling av perifere vaskulaere sykdommer | |
WO2007143607A3 (en) | Method of treating atrophic vaginitis | |
WO2007070052A3 (en) | Pharmaceutical compositions and methods for treating or preventing oxalate-related disease | |
EA200802166A1 (ru) | Стабильная фармацевтическая композиция с защитным действием от раздражения (варианты), способ ее получения и способ лечения кальций-миметиком с ее помощью | |
NO20083885L (no) | Fremgangsmate for behandling av inflammatoriske sykdommer | |
WO2008148074A3 (en) | Inhibitors of mtor and methods of treatment using same | |
EA201070477A1 (ru) | Транс-кломифен для лечения метаболического синдрома | |
DE602005021770D1 (de) | Indol-1-yl-essigsäurederivate | |
BRPI0922789A2 (pt) | peptídeo de ligação de albumina intermediador para reconhecimento de doença | |
RS52867B (en) | GLATIRAMER ACETATOM AND RAZAGILIN COMBINED THERAPY FOR MULTIPLE SCLEROSIS | |
EA200901237A1 (ru) | Применение димирацетама при лечении хронической боли | |
ES2328653A1 (es) | Combinacion de sustancias activas para el tratamiento de la diabetes. | |
CL2007003284A1 (es) | Composicion farmaceutica que comprende una asociacion de i) ciclobenzaprina, ii) aceclofenaco y opcionalmente iii) excipientes; y su uso para el tratamiento de enfermedades musculares dolorosas. |